{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:47:45Z","timestamp":1740181665317,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Epileptologica"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Smith-Kingsmore syndrome (SKS) is a rare autosomal dominant disorder caused by <jats:italic>de novo<\/jats:italic> mutations of gene <jats:italic>MTOR<\/jats:italic> in most cases and germline mosaicism in a few cases. The first case of SKS was reported in 2013. The incidence of SKS remains unknown. The clinical manifestations of SKS are diverse, and common features are macrocephaly, intellectual disability, and seizures. Some patients with SKS have special facial features.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The case was a 5-month-old baby girl, who was admitted to the hospital for nystagmus, delayed development for 2 months, and intermittent convulsions for 2 days. The patient had a head circumference of 42\u00a0cm (+\u20092SD), and showed facial deformity, low limb muscle tension, large areas of pigmentation, as well as mosaic patchy and strip-like pigment loss in her trunk and limbs. Meanwhile, her development was lagging behind peers. Physical examination did not reveal other abnormalities. She was diagnosed with SKS based on whole-exome sequencing combined with clinical symptoms and signs. She successively received treatment with adrenocorticotropic hormone, methylprednisolone sodium succinate, topiramate, levetiracetam, and zonisamide to reduce the number of convulsions in a short time, but drug resistance appeared thereafter. After combined treatment with multiple antiseizure medications, the patient still had seizures, but the amplitude of limb movement during the seizures was reduced compared to that before treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case expanded the phenotypic spectrum of SKS for diagnosis. We also review the related literature to promote the awareness, diagnosis, clinical management, and follow-up of SKS patients with <jats:italic>MTOR<\/jats:italic> mutations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42494-023-00135-2","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:01:52Z","timestamp":1697176912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Smith-Kingsmore syndrome with nystagmus as the initial symptom"],"prefix":"10.1186","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-2836","authenticated-orcid":false,"given":"Meiling","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shicheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"135_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4137\/JGE.S12583","volume":"2","author":"LD Smith","year":"2013","unstructured":"Smith LD, Saunders CJ, Dinwiddie DL, Atherton AM, Miller NA, Soden EG, et al. Exome sequencing reveals de novo germline mutation of mammalian target of rapamycin (MTOR) in a patient with megalencephaly and intractable seizures. J Genomes Exomes. 2013;2:63\u201372.","journal-title":"J Genomes Exomes"},{"issue":"1","key":"135_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ajmg.a.37999","volume":"173","author":"S Moosa","year":"2017","unstructured":"Moosa S, B\u00f6hrer-Rabel H, Altm\u00fcller J, Beleggia F, N\u00fcrnberg P, Li Y, et al. Smith-Kingsmore syndrome: a third family with the MTOR mutation c.5395G > A p.(Glu1799Lys) and evidence for paternal gonadal mosaicism. Am J Med Genet A. 2017;173(1):264\u20137.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"135_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/cge.13135","volume":"93","author":"G Gordo","year":"2018","unstructured":"Gordo G, Tenorio J, Arias P, Santos-Simarro F, Garc\u00eda-Mi\u00f1aur S, Moreno JC, et al. mTOR mutations in Smith-Kingsmore syndrome: four additional patients and a review. Clin Genet. 2018;93(4):762\u201375.","journal-title":"Clin Genet"},{"issue":"9","key":"135_CR4","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/s41431-019-0418-1","volume":"27","author":"ME Rodr\u00edguez-Garc\u00eda","year":"2019","unstructured":"Rodr\u00edguez-Garc\u00eda ME, Cotrina-Vinagre FJ, Bellusci M, Mart\u00ednez de Arag\u00f3n A, Hern\u00e1ndez-S\u00e1nchez L, Carnicero-Rodr\u00edguez P, et al. A novel de novo MTOR gain-of-function variant in a patient with Smith-Kingsmore syndrome and antiphospholipid syndrome. Eur J Hum Genet. 2019;27(9):1369\u201378.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"135_CR5","doi-asserted-by":"publisher","first-page":"P27","DOI":"10.5734\/JGM.2019.16.1.27","volume":"16","author":"D Lee","year":"2019","unstructured":"Lee D, Jang JH, Lee CG. Smith-Kingsmore syndrome: the first report of a korean patient with the MTOR germline mutation c.5395G > A p. (Glu1799Lys). J Genet Med. 2019;16(1):27-30.","journal-title":"J Genet Med"},{"issue":"3","key":"135_CR6","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1212\/NXG.0000000000000432","volume":"6","author":"A Elizondo-Plazas","year":"2020","unstructured":"Elizondo-Plazas A, Ibarra-Ram\u00edrez M, Garza-B\u00e1ez A, Mart\u00ednez-de-Villarreal LE. Expanding the phenotype of MTOR-related disorders and the Smith-Kingsmore syndrome. Neurol Genet. 2020;6(3)e432.","journal-title":"Neurol Genet"},{"issue":"5","key":"135_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/cge.13931","volume":"99","author":"D Carli","year":"2021","unstructured":"Carli D, Ferrero GB, Fusillo A, Coppo P, La Selva R, Zinali F, et al. A new case of Smith-Kingsmore syndrome with somatic MTOR pathogenic variant expands the phenotypic spectrum to lateralized overgrowth. Clin Genet. 2021;99(5):719\u201323.","journal-title":"Clin Genet"},{"issue":"7","key":"135_CR8","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/diagnostics11071269","volume":"11","author":"K Szcza\u0142uba","year":"2021","unstructured":"Szcza\u0142uba K, Rydzanicz M, Walczak A, Kosi\u0144ska J, Koppolu A, Biernacka A, et al. Brain tissue low-level mosaicism for MTOR Mutation Causes Smith-Kingsmore phenotype with recurrent Hypoglycemia-A Novel phenotype and a further proof for testing of an affected Tissue. Diagnostics (Basel). 2021;11(7)1269.","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"135_CR9","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/ajmg.a.62350","volume":"185","author":"RL Poole","year":"2021","unstructured":"Poole RL, Curry PDK, Marcinkute R, Brewer C, Coman D, Hobson E, et al. Delineating the Smith-Kingsmore syndrome phenotype: investigation of 16 patients with the MTOR c.5395G > A p.(Glu1799Lys) missense variant. Am J Med Genet A. 2021;185(8):2445\u201354.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"135_CR10","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1212\/NXG.0000000000000118","volume":"2","author":"RS M\u00f8ller","year":"2016","unstructured":"M\u00f8ller RS, Weckhuysen S, Chipaux M, Marsan E, Taly V, Bebin EM, et al. Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy. Neurol Genet. 2016;2(6):e118.","journal-title":"Neurol Genet"},{"issue":"8","key":"135_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/ng.2329","volume":"44","author":"JH Lee","year":"2012","unstructured":"Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, Heiberg A, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet. 2012;44(8):941\u20135.","journal-title":"Nat Genet"},{"issue":"7","key":"135_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009651","volume":"17","author":"AD Besterman","year":"2021","unstructured":"Besterman AD, Althoff T, Elfferich P, Gutierrez-Mejia I, Sadik J, Bernstein JA, et al. Functional and structural analyses of novel Smith-Kingsmore Syndrome-Associated MTOR variants reveal potential new mechanisms and predictors of pathogenicity. PLoS Genet. 2021;17(7):e1009651.","journal-title":"PLoS Genet"},{"key":"135_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.seizure.2021.12.004","volume":"95","author":"CM Bo\u00dfelmann","year":"2021","unstructured":"Bo\u00dfelmann CM, Antonio-Arce VS, Schulze-Bonhage A, Fauser S, Zacher P, Mayer T, et al. Genetic testing before epilepsy surgery - an exploratory survey and case collection from german epilepsy centers. Seizure. 2021;95:4\u201310.","journal-title":"Seizure"},{"key":"135_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42494-020-00024-y","volume":"2","author":"F Meng","year":"2020","unstructured":"Meng F, Yao L. The role of inflammation in epileptogenesis. Acta Epileptologica. 2020;2:15.\u00a0","journal-title":"Acta Epileptologica"},{"key":"135_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00367","author":"R Cao","year":"2018","unstructured":"Cao R. mTOR signaling, translational control, and the circadian clock. Front Genet. 2018;9:367.\u00a0","journal-title":"Front Genet"},{"issue":"8","key":"135_CR16","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41436-021-01161-6","volume":"23","author":"V Carmignac","year":"2021","unstructured":"Carmignac V, Mignot C, Blanchard E, Kuentz P, Aubriot-Lorton MH, Parker VER, et al. Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities. Genet Med. 2021;23(8):1484\u201391.","journal-title":"Genet Med"},{"issue":"1","key":"135_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/09273972.2019.1668028","volume":"28","author":"FB Wang","year":"2020","unstructured":"Wang FB. Nystagmus associated with macular dysplasia. Strabismus. 2020;28(1):17\u20139.\u00a0","journal-title":"Strabismus"},{"key":"135_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100873","volume":"20","author":"T Etheridge","year":"2020","unstructured":"Etheridge T, Kellom ER, Sullivan R, Ver Hoeve JN, Schmitt MA. Ocular evaluation and genetic test for an early Alstr\u00f6m Syndrome diagnosis. Am J Ophthalmol Case Rep. 2020;20:100873.","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"9","key":"135_CR19","doi-asserted-by":"publisher","first-page":"12502","DOI":"10.1096\/fj.202000612R","volume":"34","author":"YM Go","year":"2020","unstructured":"Go YM, Zhang J, Fernandes J, Litwin C, Chen R, Wensel TG, et al. MTOR-initiated metabolic switch and degeneration in the retinal pigment epithelium. FASEB J. 2020;34(9):12502\u201320.","journal-title":"FASEB J"}],"container-title":["Acta Epileptologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-023-00135-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42494-023-00135-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-023-00135-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T01:04:43Z","timestamp":1700269483000},"score":1,"resource":{"primary":{"URL":"https:\/\/aepi.biomedcentral.com\/articles\/10.1186\/s42494-023-00135-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1186\/s42494-023-00135-2","relation":{},"ISSN":["2524-4434"],"issn-type":[{"type":"electronic","value":"2524-4434"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"26 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the hospital ethics committee (AF-IRB-032-06) and informed consent was obtained from the patient\u2019s parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The written informed consent for publication was obtained from the patient\u2019s parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}